India Banned Export Of Malaria Drugs Which U.S President Donald Trump Believes Can Treat CO.VID-19

India has banned the export of hydroxychloroquine, a drug to treat malaria which the U.S president Donald Trump recently praised as the gamer changer that can cure patients of CO.VID-19.

On April 4, the Directorate General of Foreign Trade of India said that exports of hydroxychloroquine and its formulations were prohibited without any exceptions.

Last month, the trade regulator announced a limited ban on the export of the drug, leaving a small window for meeting prior commitment and serving on humanitarian grounds.

On Saturday, U.S president Donald Trump spoke to PM Narendra Modi asking India to release the shipment of the drug to fulfill the U.S’s orders. PM Modi said that he would consider the appeal.

On Sunday, the U.S president announced that the country had secured 29 million pills of hydroxychloroquine or choloroquine, all while praising the effect of the drug against CO.VID-19. So far, there has not been any concrete scientific proof of hydroxychloroquine being able to treat patients with the Coronavirus.

On the same day, Jerome Adams, U.S. Surgeon General, said there were some stories of the drug having a certain effect on CO.VID-19. He also said they felt safer using hydroxychloroquine then they did about a completely new drug, even though to treat CO.VID-19, a much higher dose is required.

This fuss over the malaria drug happens amid the lack of scientific evidence of its effect on the current pandemic. Moreover, hydroxychloroquine has not been approved by the U.S Food and Drug Administration to treat CO.VID-19.

>>> [Video] New Level Of Stupidity: UK Citizens Burn Down 5G Towers Thinking They Spread The Co.ro.na.virus